SEAN WALSH: Open Payments
NPI 1962896746 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,270 in 128 payments from 23 companies in 2025. Trend: 2023 $1,941 · 2024 $2,777 · 2025 $3,270
Food & beverage: $3,084Education: $133Consulting: $53
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 36 | $1,111 |
| GENZYME CORPORATION | 19 | $498 |
| GlaxoSmithKline, LLC. | 23 | $384 |
| BioCryst US Sales Co., LLC | 5 | $140 |
| Amgen Inc. | 6 | $122 |
| Verona Pharma, Inc. | 4 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $115 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| CSL Behring | 4 | $99 |
| Blueprint Medicines Corporation | 3 | $86 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, AIRSUPRA, NUCALA, ORLADEYO, Ohtuvayre, AYVAKIT.
Industry payments across AK — which companies pay providers there.
